ODYSSEY – Type 2 Diabetes and High Cholesterol

CONDITION

Metabolic and Endocrine

GENDER

Both males and females

AGE GROUP

From 18

and above

STATUS

Recruiting

We are testing the effect of an investigational drug on reducing cholesterol in patients with Type 2 Diabetes who may be at risk of developing coronary heart disease.

You may qualify for this trial is you:

  • are over 18
  • have Type 2 Diabetes
  • have high cholesterol

Please note this trial is ethics approved, you will be medically supervised, and no costs are involved. Participation in this trial is voluntary.

If you are interested in learning more about this study, please contact our friendly research team.

CONTACT DETAILS

Phone Number: 02 4963 2323 (take option 1)

Email: kate@aimcentre.com.au

Location: 41 Llewellyn St, Merewether, New South Wales, Australia

Approved By: Belberry Human Research Ethics              

Clinical Trial Registry Link: